Filed before 2025Filed 2 March 2022
Sudo Biosciences, Inc. has sold $22.2M so far
Sudo Biosciences, Inc., a technology company based in Menlo Park, CA, has sold $22.2M so far in its equity round, according to a filing dated 2 March 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 2 March 2022
- First filed
- 5 May 2021
- Round
- Equity round (amended filing)
- Amount sold
- $22.2M
- Offering size
- $22.2M
- Investors so far
- 6
- Based in
- Menlo Park, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 73% of the 1,764 tracked raises with an amount filed in 2022, and than 72% of the 904 in technology.
Sudo Biosciences, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 15 Feb 2024 | Amended filing | $63.6M | Another raise |
| 28 Dec 2023 | New filing | $53.3M | Another raise |
| 2 Mar 2022 | Amended filing | $22.2M | This raise |
| 5 May 2021 | New filing | $9.52M | This raise |
More with Frazier Life Sciences on the board
- Enlaza Therapeutics, Inc.$15M
- MBX Biosciences, Inc.$46.7M
- 98point6 Inc.$20.9M
- Scout Bio, Inc.$4.75M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.